ARQT
Arcutis Biotherapeutics Inc
NASDAQ: ARQT · HEALTHCARE · BIOTECHNOLOGY
$22.37
-3.95% today
Updated 2026-04-29
Market cap
$2.91B
P/E ratio
—
P/S ratio
7.75x
EPS (TTM)
$-0.13
Dividend yield
—
52W range
$12 – $32
Volume
1.3M
Arcutis Biotherapeutics Inc (ARQT) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
8 of 8
Last 8 quarters
Avg EPS surprise
+59.2%
Last 4 quarters
Revenue YoY growth
+81.5%
Most recent quarter
EPS YoY growth
+244.4%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+6.9%
Last 3 reports
Positive reaction rate
33%
1 of 3 quarters
Largest single-day move
+28.8%
2025-10-28
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-26 | $0.13 | +46.7% | $27.01 | $26.97 | -0.1% |
| 2025-10-28 | $0.06 | +166.7% | $19.64 | $25.29 | +28.8% |
| 2025-08-06 | $-0.13 | +18.8% | $15.33 | $14.12 | -7.9% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $0.09 | $0.13 | +46.7% | $129.50M | +81.5% |
| 2025-09-30 | $-0.09 | $0.06 | +166.7% | $99.22M | +121.7% |
| 2025-06-30 | $-0.16 | $-0.13 | +18.8% | $81.50M | +164.1% |
| 2025-03-31 | $-0.21 | $-0.20 | +4.8% | $65.85M | +32.8% |
| 2024-12-31 | $-0.26 | $-0.09 | +65.9% | $71.36M | +427.6% |
| 2024-09-30 | $-0.42 | $-0.33 | +21.4% | $44.76M | +17.4% |
| 2024-06-30 | $-0.53 | $-0.42 | +20.8% | $30.86M | +494.6% |
| 2024-03-31 | $-0.73 | $-0.32 | +56.2% | $49.57M | — |
| 2023-12-31 | $-0.80 | $-0.72 | +10.0% | $13.53M | — |
| 2023-09-30 | $-0.91 | $-0.73 | +19.8% | $38.11M | — |
| 2023-06-30 | $-1.25 | $-1.16 | +7.2% | $5.19M | — |
Frequently asked questions
Has Arcutis Biotherapeutics Inc beaten earnings estimates?
Arcutis Biotherapeutics Inc has beaten Wall Street EPS estimates in 8 of its last 8 quarterly reports, with an average EPS surprise of +59.2% over the last 4 quarters.
How does ARQT stock react to earnings?
ARQT stock has moved an average of +6.9% in the trading day following earnings over its last 3 reports, with positive reactions in 33% of those quarters.
What is Arcutis Biotherapeutics Inc's revenue growth rate?
Arcutis Biotherapeutics Inc reported year-over-year revenue growth of +81.5% in its most recent quarter, with EPS growing +244.4% year-over-year.